MaRS Impact Health

Torys’ Intellectual Property and Food and Drug Regulatory partner Eileen McMahon will speak at the MaRS Impact Health conference taking place from May 25 to 27 in Toronto. The three-day event will provide insights from health and biotech investors, help attendees understand how industry insiders, healthcare providers and governments look to change practices, procedures and infrastructure post pandemic.

Eileen will speak on the “Invention to market: Open science and commercialization” panel on May 27 at 10:00 a.m. This session will discuss topics like the latest models for bringing life science innovation to the market, the pressure and partnership between intellectual property and open science in drug discovery.

You can learn more about this session and others on the MaRS website.